QuidelOrtho Corporation
NASDAQ Global SelectTotal Valuation
QuidelOrtho Corporation carries a market capitalization of 952.63M, placing it among publicly traded companies globally. Its enterprise value stands at 4.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 952.63M |
| Enterprise Value | 4.15B |
Share Statistics
QuidelOrtho Corporation currently has 68.30M shares outstanding.
| Shares Outstanding | 68.30M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.45, and the price-to-book ratio stands at 0.67.
| PE Ratio | N/A |
| PS Ratio | 0.45 |
| PB Ratio | 0.67 |
| P/TBV Ratio | -1.32 |
| P/FCF Ratio | 12.33 |
| P/OCF Ratio | -20.87 |
Enterprise Valuation
On an enterprise value basis, QuidelOrtho Corporation trades at an EV/EBITDA multiple of 9.89 and an EV/FCF ratio of 13.96. The EV/Sales ratio of 1.55 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 128.24 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.55 |
| EV / EBITDA | 9.89 |
| EV / EBIT | 128.24 |
| EV / FCF | 13.96 |
Financial Position
QuidelOrtho Corporation maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 173.27, indicating elevated leverage, while an interest coverage ratio of 2.13 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.39 |
| Quick Ratio | 0.60 |
| Debt / Equity | 173.27 |
| Debt / EBITDA | 7.33 |
| Interest Coverage | 2.13 |
Financial Efficiency
| Return on Equity (ROE) | -45.91 |
| Return on Assets (ROA) | -17.34 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.47 |
Taxes
| Income Tax | 18.40M |
| Effective Tax Rate | N/A |
Stock Price Statistics
QuidelOrtho Corporation's stock has declined approximately -49.73012% over the past 52 weeks. The 50-day moving average sits at 15.96, while the 200-day moving average is 19.48.
| Beta (5Y) | N/A |
| 52-Week Price Change | -49.73012% |
| 50-Day Moving Average | 15.96 |
| 200-Day Moving Average | 19.48 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, QuidelOrtho Corporation generated 2.67B in revenue and converted that into -1.05B in net income, yielding earnings per share of -15.39. EBITDA reached 419.40M, while operating income came in at -34.80M.
| Revenue | 2.67B |
| Gross Profit | 1.19B |
| Operating Income | -34.80M |
| Pretax Income | -1.03B |
| Net Income | -1.05B |
| EBITDA | 419.40M |
| EBIT | -34.80M |
| Earnings Per Share (EPS) | -15.39 |
Balance Sheet
QuidelOrtho Corporation holds 123.40M in cash and equivalents against 3.08B in total debt, resulting in a net debt position of 2.77B. Total book value stands at 1.77B, with working capital of 383.20M providing operational flexibility.
| Cash & Cash Equivalents | 123.40M |
| Total Debt | 3.08B |
| Net Debt | 2.77B |
| Equity (Book Value) | 1.77B |
| Book Value Per Share | 25.99 |
| Working Capital | 383.20M |
Cash Flow
QuidelOrtho Corporation produced -57.20M in operating cash flow over the past twelve months. After subtracting -154.00M in capital expenditures, free cash flow totaled -211.20M - equivalent to -3.10 per share.
| Operating Cash Flow | -57.20M |
| Capital Expenditures | -154.00M |
| Free Cash Flow | -211.20M |
| FCF Per Share | -3.10 |
Margins
QuidelOrtho Corporation operates with a gross margin of 44.60, reflecting its pricing power and cost economics. The operating margin of -1.30 and net profit margin of -39.20 provide insight into operational efficiency.
| Gross Margin | 44.60 |
| Operating Margin | -1.30 |
| Pretax Margin | -38.52 |
| Profit Margin | -39.20 |
| EBITDA Margin | 15.68 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -22.82 |
| FCF Yield | 8.11 |
Scores
QuidelOrtho Corporation posts an Altman Z-Score of 0.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.63 |